India may go for joint production of Covid-19 vaccine in some countries

India today indicated it may go for joint production of Covid-19 vaccine in some countries and is exploring the possibility of conducting phase-3 human trials in a "few of our partner nations."

Foreign Secretary Harsh Vardhan Shringla said "we are exploring the possibility of conducting phase III trials in a few of our partner countries. We are also looking forward to research collaboration in the field of vaccine development. Based on willingness, we may also go for joint production of vaccines in some countries."

He said India has already conducted online training sessions for nearly 90 participants from eight neighbouring countries to develop capacity in clinical trials and clinical practices. "Based on demand, we can conduct more such training courses," Shrignla added, according to our New Delhi correspondent.

Bangladesh is among the eight countries with which India is in talks to hold phase 3 clinical trials.

"We are on track for development and trial of vaccines," the Foreign Secretary said while briefing the diplomatic corps and representatives of international organisations in New Delhi on India's Covid-19 response and vaccine development programme.

Shringla said several countries have been approaching India for receiving vaccine supply. "India will help interested countries in enhancing their cold chain and storage capacities for the delivery of vaccines," he said.